Why is Morepen Labs. falling/rising?

As of 28-Aug, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 46.86, which reflects a decrease of 0.45 or 0.95%. The stock has been underperforming, with a consecutive fall over the last five days resulting in a total decline of 5.79%. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock has generated a return of -41.24% over the past year, with a significant drop in net sales and profits, which fell by 21.3%. The company has reported negative results for the last two consecutive quarters, further contributing to investor concerns. Despite a low debt-to-equity ratio and attractive valuation metrics, the overall sentiment remains negative due to poor long-term growth prospects.
In the broader market context, Morepen Laboratories Ltd's short-term performance has been notably worse than the benchmark, with a 1-week return of -4.79% compared to the Sensex's decline of only 2.34%. This underperformance is compounded by a significant drop in investor participation, as evidenced by a 45.89% decrease in delivery volume against the 5-day average. The lack of domestic mutual fund investment, which stands at 0%, suggests a lack of confidence in the stock's future performance. Overall, the combination of declining sales, poor quarterly results, and weak investor interest has led to the stock's downward trajectory.